Allred Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$512K Buy
8,145
+545
+7% +$38K 0.19% 99
2025
Q4
$504K Sell
7,600
-1,372
-15% -$88.7K 0.18% 106
2025
Q3
$604K Buy
8,972
+1,199
+15% +$94.9K 0.21% 101
2025
Q2
$679K Buy
7,773
+266
+4% +$20.9K 0.25% 86
2025
Q1
$513K Buy
7,507
+3,886
+107% +$317K 0.2% 99
2024
Q4
$282K Sell
3,621
-706
-16% -$52.3K 0.11% 147
2024
Q3
$290K Buy
4,327
+24
+0.6% +$1.97K 0.11% 136
2024
Q2
$488K Buy
4,303
+608
+16% +$76.9K 0.19% 109
2024
Q1
$512K Buy
+3,695
New +$464K 0.2% 106
2021
Q2
Sell
-36
Closed -$3.23K 348
2021
Q1
$3.23K Buy
+36
New +$3.38K ﹤0.01% 724
2020
Q1
Sell
-56
Closed -$3.06K 291
2019
Q4
$3.06K Buy
+56
New +$2.66K ﹤0.01% 743

Other funds holding DXCM

Allred Capital Management's DXCM Position: Q1 2026 in Review

Allred Capital Management increased its DexCom (DXCM) stake by 7.2% in Q1 2026, buying an estimated $38K and bringing the position to 8,145 shares worth $512K. The position accounts for 0.19% of the portfolio, ranked #99.

Allred Capital Management first reported a position in DXCM in Q4 2019 and has held it in 11 quarters since. The position peaked at $679K in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Allred Capital Management held 8,145 shares of DexCom worth $512K as of Q1 2026.
  • Allred Capital Management bought 545 DexCom shares in Q1 2026, an estimated $38K.
  • DexCom made up 0.19% of Allred Capital Management's portfolio in Q1 2026, its #99 holding.
  • Allred Capital Management first reported a position in DexCom in Q4 2019 and has held it in 11 quarters since.
  • Allred Capital Management's DexCom position peaked at $679K in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Allred Capital Management's 13F filing for Q1 2026, filed 14 May 2026.